Projects with WHO

Sepsis Working Group

  • April 2009: meeting for initial development of algorithm for the management of severe sepsis and respiratory failure without shock in resource-constrained settings
  • September 2009: follow-up meeting for severe sepsis management algorithm and further development of IMAI multi-country evaluation protocol to study efficacy and effectiveness of algorithm for management of sepsis and respiratory failure

Integrated Management of Adult and Adolescent Illness (IMAI)

  • June 2009: initial development of multi-country evaluation protocol to study efficacy and effectiveness of algorithm for management of sepsis and respiratory failure
  • September 2009-present: continued development of IMAI protocol to study efficacy and effectiveness of algorithm for management of sepsis and respiratory failure
  • April 2009-present: contributors to IMAI District Clinician Manual
  • June 2010-present: development of “IMAI triage/ quick check and management of the severely ill patient—septic shock and respiratory failure without shock” Training Module
  • May 2011-present: technical editor to 2-volume IMAI District Clinican Manual
  • August 2011: facilitation of 5-day course for “IMAI triage/ quick check and management of the severely ill patient—septic shock and respiratory failure without shock” Training Module in Kampala Uganda

Global Influenza Program

  • October 2009-January 2010: secundment to WHO for technical expertise during H1N1 global pandemic
  • December 2009: development of “Critical Care” Training Modules for middle income countries during H1N1 pandemic
  • August 2011: Contract to review literature on clinical management of severe influenza
  • November 2012: technical consultation on research needs for the battle against respiratory viruses
Emerging Infectious Disease Network
  • December 2011: INTERSECT/WHO/PAHO/NIH co-sponsored satellite symposium at the 2011 American Society of Tropical Medicine and Hygiene annual meeting to bring together network collaborators interested in improving clinical management of severe EID, promote scientific research, and develop partner capacity